Table 2.
(a) | ||||||
---|---|---|---|---|---|---|
All participants (N = 2678) Self‐reported latest viral load | Clinic‐recorded viral load (latest result available to participant) | |||||
≤ 50 copies/mL (N = 2334) | > 50 copies/mL (N = 344) | |||||
n | Column % | Row % | n | Column % | Row % | |
≤ 50 copies/mLb (N = 2137) | 2061 | 88.3 | 96.4 | 76 | 22.1 | 3.6 |
> 50 copies/mLc (N = 232) | 49 | 2.1 | 21.1 | 183 | 53.2 | 78.9 |
Don't know (N = 309) | 224 | 9.6 | 72.5 | 85 | 24.7 | 27.5 |
MSM (N = 1852) Self‐reported latest viral load |
≤ 50 copies/mL (N = 1638) | > 50 copies/mL (N = 214) | ||||
---|---|---|---|---|---|---|
n | Column % | Row % | n | Column % | Row % | |
≤ 50 copies/mLb (N = 1555) | 1500 | 91.6 | 96.5 | 55 | 25.7 | 3.5 |
> 50 copies/mLc (N = 157) | 30 | 1.8 | 19.1 | 127 | 59.3 | 80.9 |
Don't know (N = 140) | 108 | 6.6 | 77.1 | 32 | 15.0 | 22.9 |
Heterosexual men and women (N = 826) Self‐reported latest viral load |
≤ 50 copies/mL (N = 696) | > 50 copies/mL (N = 130) | ||||
---|---|---|---|---|---|---|
n | Column % | Row % | n | Column % | Row % | |
≤ 50 copies/mLb (N = 582) | 561 | 80.6 | 96.4 | 21 | 16.2 | 3.6 |
> 50 copies/mLc (N = 75) | 19 | 2.7 | 25.3 | 56 | 43.1 | 74.7 |
Don't know (N = 169) | 116 | 16.7 | 68.6 | 53 | 40.8 | 31.4 |
(b) | ||||||
---|---|---|---|---|---|---|
All participants (N = 2667) Self‐reported CD4 count (cells/μL) |
Clinic‐recorded CD4 count (cells/μL) (latest result available to participant) | |||||
≤ 350 (N = 484) | > 350 (N = 2183) | |||||
n | Column % | Row % | n | Column % | Row % | |
< 200 (N = 258) | 132 | 27.3 | 51.2 | 126 | 5.8 | 49.8 |
200–350 (N = 378) | 238 | 49.2 | 63.0 | 140 | 6.4 | 37.0 |
351–500 (N = 632) | 56 | 11.6 | 8.9 | 576 | 26.4 | 91.1 |
> 500 (N = 1118) | 9 | 1.9 | 0.8 | 1109 | 50.8 | 99.2 |
Don't know (N = 281) | 49 | 10.1 | 17.4 | 232 | 10.6 | 82.6 |
MSM (N = 1840) Self‐reported CD4 count (cells/μL) |
≤ 350 (N = 282) | > 350 (N = 1558) | ||||
---|---|---|---|---|---|---|
n | Column % | Row % | n | Column % | Row % | |
< 200 (N = 156) | 80 | 28.4 | 51.3 | 76 | 4.9 | 48.7 |
200–350 (N = 257) | 155 | 55.0 | 60.3 | 102 | 6.5 | 39.7 |
351–500 (N = 458) | 29 | 10.3 | 6.3 | 429 | 27.5 | 93.7 |
> 500 (N = 845) | 7 | 2.5 | 0.8 | 838 | 53.8 | 99.2 |
Don't know (N = 124) | 11 | 3.9 | 8.9 | 113 | 7.3 | 91.1 |
Clinic‐recorded CD4 count (cells/μL) (latest result available to participant) | ||||||
---|---|---|---|---|---|---|
Heterosexual men and women (N = 827) Self‐reported CD4 count (cells/μL) |
≤ 350 (N = 202) | > 350 (N = 625) | ||||
n | Column % | Row % | n | Column % | Row % | |
< 200 (N = 102) | 52 | 25.7 | 51.0 | 50 | 8.0 | 49.0 |
200–350 (N = 121) | 83 | 41.1 | 68.6 | 38 | 6.1 | 31.4 |
351–500 (N = 174) | 27 | 13.4 | 15.5 | 147 | 23.5 | 84.5 |
> 500 (N = 273) | 2 | 1.0 | 0.7 | 271 | 43.4 | 99.3 |
Don't know (N = 157) | 38 | 18.8 | 24.2 | 119 | 19.0 | 75.8 |
MSM, men who have sex with men.
The analysis excludes 93 of 2771 individuals on ART. Exclusions were: missing clinic‐recorded viral load (n = 18); clinic‐recorded viral load dated after questionnaire issue (n = 11); missing self‐reported viral load (n = 64).
The analysis excludes 104 of 2771 individuals on ART. Exclusions were: missing clinic‐recorded CD4 count (n = 19); clinic‐recorded CD4 count dated after questionnaire issue (n = 15); missing self‐reported CD4 count (n = 70).
50 copies/mL or less (‘undetectable’ or ‘suppressed’).
More than 50 copies/mL (‘detectable’ or ‘raised’).